Women’s health is one of the fastest-growing probiotic applications. According to Future Market Insights, the women’s probiotic market, valued at roughly $1.8 billion in 2025, is projected to grow nearly 18% annually through 2035, reaching close to $9.6 billion. This momentum reflects growing consumer understanding of the microbiome’s importance in vaginal health, urinary health, and menopausal comfort.
In a groundbreaking Phase 1 randomized clinical trial, researchers found that a short course of a multi-strain probiotic significantly reduced bacterial vaginosis (BV) recurrence. Globally, BV affects approximately 30% of women and is associated with increased risk for preterm birth and HIV acquisition. After antibiotic treatment, up to 60% of women have BV again within six months. This multi-strain probiotic approach restored protective bacteria to the vagina, offering a promising new solution.
According to a review published in Frontiers in Microbiology, the healthy vaginal microecosystem dominated by Lactobacillus safeguards against pathogenic microorganisms and maintains overall reproductive health by producing antimicrobial substances and sustaining an acidic environment. The review systematically summarizes current mechanistic understanding of Lactobacillus-mediated VMB homeostasis and evaluates the therapeutic potential of probiotics.
With more women seeking natural, non-hormonal options to address overall well-being, probiotics are becoming an important part of holistic women’s health.
Women’s health is one of the fastest-growing probiotic applications. According to Future Market Insights, the women’s probiotic market, valued at roughly $1.8 billion in 2025, is projected to grow nearly 18% annually through 2035, reaching close to $9.6 billion. This momentum reflects growing consumer understanding of the microbiome’s importance in vaginal health, urinary health, and menopausal comfort.
Gut health innovation moved into a new phase of maturity in 2025. No longer solely driven by live microbial counts or broad probiotic positioning, brands and manufacturers are now relying on more precise ingredient classes such as postbiotics, structured fibers, standardized fermentates, and defined metabolites.
The global probiotics market is entering a new phase of structurally strong growth. According to MarketsandMarkets, the market was valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% during the forecast period. This expansion reflects a fundamental shift in consumer behavior toward long-term wellness and preventive nutrition.
A Bacillus coagulans BCN019 with anti fatigue effect and its bacterial agent and application ZL 202111335753.4Supported by patents, the formula is unique. By promoting nutrient absorption, reducing the number of intestinal bacteria, reducing fatigue after exercise, improving intestinal health, enhancing immunity, assisting weight loss, preventing infections, and regulating intestinal microbiota, probiotic special diets can provide strong protection for the health and exercise performance of athletes.
The reexamination and recognition of high-tech enterprises fully reflects the Zhongke-Jiayi Probiotics company's further recognition by relevant national regulatory authorities in terms of intellectual property rights, technology transfer capabilities,R&D organization and management capabilities, and enterprise growth. It is of great significance to demonstrate the company's comprehensive strength and promote the sustained, healthy, and high-quality development of the enterprise.
Lactobacillus plantarum JYLP-326 is a patented strain in the field of sleep, and its metabolites can stimulate the brain γ- The secretion of aminobutyric acid increases the secretion of night pineal hormone, promotes sleep, and improves sleep quality.freeze dried probiotics powder Anxiety is mainly due to nervousness, nervousness, and people always feel uneasy.
From November 28th to 30th, 2023 European Food Ingredients and Natural Ingredients Exhibition Fi Europewas successfully held in Frankfurt, Germany. This exhibition brings together food ingredient suppliers, purchasers, and technology exporters from around the world, providing an excellent opportunity for communication and exchange among exhibitors.
Obesity is a chronic metabolic disease caused by multiple factors, characterized by an increase in the volume and number of adipocytes in the body, resulting in an abnormally high percentage of body fat to body weight and excessive deposition of fat in certain areas. At present, the number of obese people in China has exceeded 250 million, and the trend is still on the rise. Overweight or obesity can increase the risk of breast cancer, coronary heart disease, type 2 diabetes, gallbladder disease, osteoarthritis, colon cancer, hypertension and stroke.
Zhongke-Jiayi Probiotics will attend the exhibition “Food Ingredients Europe 2023”freeze dried probiotics powder Shandong Zhongke-Jiayi Bioengineering Co.,Ltd will attend the exhibition “Food Ingredients Europe 2023” in Frankfurt,
Fertility has always been an important research issue in the field of life sciences. In recent years, the incidence of male and female infertility has been increasing, with male infertility accounting for about 40% to 50%. The main causes of male infertility include abnormal levels of reproductive endocrine hormones, abnormalities in the development of seminal plasmodesmata testes and epididymis, autoimmunity, spermatogenesis, and infections, etc., and are mainly manifested in semen quality abnormalities such as oligozoospermia, weak spermatozoa, and spermatozoa malformations.
Copyright © 2025 by Minsheng Zhongke-Jiayi (Shandong) Bioengineering Co., Ltd. All Rights Reserved
Privacy Policy
